Radiometals for Combined Imaging and Therapy

被引:320
作者
Cutler, Cathy S. [1 ]
Hennkens, Heather M. [1 ]
Sisay, Nebiat [1 ,2 ]
Huclier-Markai, Sandrine [3 ]
Jurisson, Silvia S. [2 ]
机构
[1] Univ Missouri, Res Reactor Ctr, Columbia, MO 65211 USA
[2] Univ Missouri, Dept Chem, Columbia, MO 65211 USA
[3] Univ Nantes, Lab Subatech, UMR 6457, Ecole Mines Nantes,CNRS IN2P3, F-44307 Nantes 3, France
关键词
POSITRON EMISSION TOMOGRAPHY; METASTATIC BONE PAIN; COPPER-64-LABELED MONOCLONAL-ANTIBODY; PARTICLE-EMITTING RADIONUCLIDES; CLUSTER-LABELED ANTIBODIES; NUCLEAR-MEDICINE THERAPY; RAY CRYSTAL-STRUCTURES; DOTA-BINDING ANTIBODY; SCHIFF-BASE COMPLEXES; IN-VIVO EVALUATION;
D O I
10.1021/cr3003104
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A study was conducted to demonstrate the use of radiometals for combined imaging and therapy. The study presented radiometals that had the nuclear properties required for use in theranostic applications for imaging and therapy. Their chemistry and production methods were discussed, along with examples of preclinical and clinical uses. A number of radiometals had been evaluated for positron emission tomography (PET) due to their favorable nuclear properties. The choice of type and energy of the particle emission was determined by the size of the lesion or tumor being treated, site of delivery, whether the tumor was homogeneous, and whether the dose was delivered uniformly to each cell. A major advantage of using such nanosized radioactive particles was their potential to contain numerous radioactive atoms within a single nanoparticle.
引用
收藏
页码:858 / 883
页数:26
相关论文
共 213 条
[1]   POLAROGRAPHY OF SOME RHODIUM(III) COMPLEXES [J].
ADDISON, AW ;
GILLARD, RD ;
VAUGHAN, DH .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1973, (11) :1187-1193
[2]   The complexation of rhodium(III) with acyclic diaminedithioether (DADTE) ligands [J].
Akgun, Zeynep ;
Engelbrecht, Hendrik ;
Fan, Kuo-Hsien ;
Barnes, Charles Leslie ;
Cutler, Cathy Sue ;
Jurisson, Silvia Sabine ;
Lever, Susan Zemyan .
DALTON TRANSACTIONS, 2010, 39 (42) :10169-10178
[3]   "Microencapsulated" and Related Catalysts for Organic Chemistry and Organic Synthesis [J].
Akiyama, Ryo ;
Kobayashi, Shu .
CHEMICAL REVIEWS, 2009, 109 (02) :594-642
[4]   KOMPLEXONE .30. DIATHYLENTRIAMIN-PENTAESSIGSAURE (DTPA) [J].
ANDEREGG, G ;
NAGELI, P ;
MULLER, F ;
SCHWARZENBACH, G .
HELVETICA CHIMICA ACTA, 1959, 42 (03) :827-836
[5]  
Anderson CJ, 2001, J NUCL MED, V42, P213
[6]  
ANDERSON CJ, 1995, J NUCL MED, V36, P2315
[7]  
ANDERSON P, 1988, NUCL MED BIOL, V15, P293
[8]   BETA-DECAY EFFECTS OF LANTHANIDE ATOMS IN CHELATE COMPOUNDS .3. BETA-DECAY EFFECTS IN VISCOUS SOLUTIONS [J].
ASANO, T ;
TANIGUCHI, S .
JOURNAL OF INORGANIC & NUCLEAR CHEMISTRY, 1978, 40 (06) :957-961
[9]   BIODISTRIBUTION OF SN-117M[4+]DTPA FOR PALLIATIVE THERAPY OF PAINFUL OSSEOUS METASTASES [J].
ATKINS, HL ;
MAUSNER, LF ;
SRIVASTAVA, SC ;
MEINKEN, GE ;
STRAUB, RF ;
CABAHUG, CJ ;
WEBER, DA ;
WONG, CTC ;
SACKER, DF ;
MADAJEWICZ, S ;
PARK, TL ;
MEEK, AG .
RADIOLOGY, 1993, 186 (01) :279-283
[10]   Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer [J].
Bander, NH ;
Milowsky, MI ;
Nanus, DM ;
Kostakoglu, L ;
Vallabhajosula, S ;
Goldsmith, SJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) :4591-4601